Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John E Tavis

Showing results (51-60 of 96) with videos related to

Pageof 10
Sort By:
Vaccine|September 9, 2020
A bivalent HCV peptide vaccine elicits pan-genotypic neutralizing antibodies in miceAlexander I Mosa, Richard A Urbanowicz, Mounir G AbouHaidar, et al.
Frontiers in Microbiology|October 5, 2020
Establishment of a Replicon Reporter of the Emerging Tick-Borne Bourbon Virus and Use It for Evaluation of AntiviralsSiyuan Hao, Kang Ning, Xiaomei Wang, et al.
Virology Journal|September 19, 2020
Role of HVR1 sequence similarity in the cross-genotypic neutralization of HCVAlexander I Mosa, Mounir G AbouHaidar, Richard A Urbanowicz, et al.
Antiviral Research|June 21, 2016
Purification and enzymatic characterization of the hepatitis B virus ribonuclease H, a new target for antiviral inhibitorsJuan Antonio Villa, Daniel P Pike, Kunjan B Patel, et al.
The Lancet. Gastroenterology & Hepatology|July 27, 2025
Patient and public health perspectives to inform expansion of hepatitis B treatment guidelinesChari Cohen, Thomas Tu, Philippa C Matthews, et al.
Plos One|August 1, 2014
HCV genome-wide genetic analyses in context of disease progression and hepatocellular carcinomaMaureen J Donlin, Elena Lomonosova, Alexi Kiss, et al.
The Journal of Experimental Medicine|June 9, 2005
Immune evasion versus recovery after acute hepatitis C virus infection from a shared sourceIan Tester, Susan Smyk-Pearson, Ping Wang, et al.
Plos One|February 9, 2010
Contribution of genome-wide HCV genetic differences to outcome of interferon-based therapy in Caucasian American and African American patientsMaureen J Donlin, Nathan A Cannon, Rajeev Aurora, et al.
Plos One|February 8, 2011
Differential in vitro effects of intravenous versus oral formulations of silibinin on the HCV life cycle and inflammationJessica Wagoner, Chihiro Morishima, Tyler N Graf, et al.
Journal of Medicinal Chemistry|August 23, 2023
Antiviral Evaluation of Dispirotripiperazines against Hepatitis B VirusThane Jones, John E Tavis, Qilan Li, et al.
Pageof 10

Showing results (51-60 of 96) with videos related to

Sort By:
Pageof 10
Vaccine|September 9, 2020
A bivalent HCV peptide vaccine elicits pan-genotypic neutralizing antibodies in miceAlexander I Mosa, Richard A Urbanowicz, Mounir G AbouHaidar, et al.
Frontiers in Microbiology|October 5, 2020
Establishment of a Replicon Reporter of the Emerging Tick-Borne Bourbon Virus and Use It for Evaluation of AntiviralsSiyuan Hao, Kang Ning, Xiaomei Wang, et al.
Virology Journal|September 19, 2020
Role of HVR1 sequence similarity in the cross-genotypic neutralization of HCVAlexander I Mosa, Mounir G AbouHaidar, Richard A Urbanowicz, et al.
Antiviral Research|June 21, 2016
Purification and enzymatic characterization of the hepatitis B virus ribonuclease H, a new target for antiviral inhibitorsJuan Antonio Villa, Daniel P Pike, Kunjan B Patel, et al.
The Lancet. Gastroenterology & Hepatology|July 27, 2025
Patient and public health perspectives to inform expansion of hepatitis B treatment guidelinesChari Cohen, Thomas Tu, Philippa C Matthews, et al.
Plos One|August 1, 2014
HCV genome-wide genetic analyses in context of disease progression and hepatocellular carcinomaMaureen J Donlin, Elena Lomonosova, Alexi Kiss, et al.
The Journal of Experimental Medicine|June 9, 2005
Immune evasion versus recovery after acute hepatitis C virus infection from a shared sourceIan Tester, Susan Smyk-Pearson, Ping Wang, et al.
Plos One|February 9, 2010
Contribution of genome-wide HCV genetic differences to outcome of interferon-based therapy in Caucasian American and African American patientsMaureen J Donlin, Nathan A Cannon, Rajeev Aurora, et al.
Plos One|February 8, 2011
Differential in vitro effects of intravenous versus oral formulations of silibinin on the HCV life cycle and inflammationJessica Wagoner, Chihiro Morishima, Tyler N Graf, et al.
Journal of Medicinal Chemistry|August 23, 2023
Antiviral Evaluation of Dispirotripiperazines against Hepatitis B VirusThane Jones, John E Tavis, Qilan Li, et al.
Pageof 10